Home » Topics » BioWorld Science

BioWorld Science
RSS

New SREBP inhibitors identified at Capulus Therapeutics

Aug. 23, 2021

Sumitomo Dainippon Pharma Oncology patents serine/threonine kinase Nek2 inhibitors

Aug. 23, 2021

Genexine describes anti-TAA, anti-PD-L1, TNFRSF9 ligand fusion proteins

Aug. 23, 2021

Clinical hold extended for ORTHO-R phase I/II study

Aug. 23, 2021

A virus-specific nanobody lowers latent viral loads in HCMV-infected cells

Aug. 23, 2021

IL-26 is involved in malignant pleural effusion and associated with poor prognosis

Aug. 20, 2021

VEGFC mRNA-LNP platform induces formation of a functional lymphatic network and reverses lymphedema

Aug. 20, 2021

[11C]MTP-38 first use in human PET studies shows promise for neurological disorders

Aug. 20, 2021

Rare gene variants increase zoonotic H7N9 susceptibility

Aug. 20, 2021

CRISPR Therapeutics AG presents new CAR Tcells for immuno-oncology

Aug. 20, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 10, 2026.
Hengrui discovers new Nav1.8 blockers
BioWorld Science
Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...
Hematopoietic stem cell research points to leukemia’s early roots
BioWorld Science
Hematopoietic stem cell (HSC) research over the past century has shown that leukemia may be driven by an invisible hand of inflammation. The bone marrow and...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 7, 2026
Korsana boosts Alzheimer’s work with reverse merger, $380M financing
BioWorld Science
Just over a month after emerging from stealth and disclosing a $150 million series A, Korsana Biosciences Inc. is making the leap to the public market via a...